Biomarkers characterization of circulating tumour cells in breast cancer patients - Wikidata - awgldk - TriplyDB

Biomarkers characterization of circulating tumour cells in breast cancer patients

Biomarkers characterization of circulating tumour cells in breast cancer patients

http://www.wikidata.org/entity/Q36245346

about

Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells Circulating tumor cells in breast cancer Strategies for modern biomarker and drug development in oncology.Fluorescence Analysis of Vitamin D Receptor Status of Circulating Tumor Cells (CTCS) in Breast Cancer: From Cell Models to Metastatic Patients Circulating tumor cells in breast cancer.EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer Heterogeneity of estrogen receptor expression in circulating tumor cells from metastatic breast cancer patients Development of a new rapid isolation device for circulating tumor cells (CTCs) using 3D palladium filter and its application for genetic analysis.Study of antitumor activity in breast cell lines using silver nanoparticles produced by yeast.The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: a retrospective study in 107 patients.Correlation of hormone receptor status between circulating tumor cells, primary tumor, and metastasis in breast cancer patients.Circulating Tumor Cells Identify Early Recurrence in Patients with Non-Small Cell Lung Cancer Undergoing Radical Resection 2-NBDG fluorescence imaging of hypermetabolic circulating tumor cells in mouse xenograft model of breast cancer Circulating tumor cell status monitors the treatment responses in breast cancer patients: a meta-analysis.Bone marrow micrometastases in early breast cancer-30-year outcome.Cytokeratin-based CTC counting unrelated to clinical follow up Prognostic Impact of HER2 and ER Status of Circulating Tumor Cells in Metastatic Breast Cancer Patients with a HER2-Negative Primary Tumor.Metastasis dormancy in estrogen receptor-positive breast cancer.Recent advances in the molecular characterization of circulating tumor cells.Unbiased quantitative assessment of Her-2 expression of circulating tumor cells in patients with metastatic and non-metastatic breast cancer.Relevance of molecular characterization of circulating tumor cells in breast cancer in the era of targeted therapies.Circulating tumour cells and cell-free DNA as tools for managing breast cancer.Colorectal cancer diagnostics: biomarkers, cell-free DNA, circulating tumor cells and defining heterogeneous populations by single-cell analysis.New frontiers in circulating tumor cell analysis: A reference guide for biomolecular profiling toward translational clinical use.Circulating tumor cells as promising novel biomarkers in solid cancers.Single-cell analysis of CTCs with diagnostic precision: opportunities and challenges for personalized medicine.Molecular Profiling and Significance of Circulating Tumor Cell Based Genetic Signatures.Ex vivo culture of circulating tumor cells using magnetic force-based coculture on a fibroblast feeder layer.Grating coupled SPR microarray analysis of proteins and cells in blood from mice with breast cancer.Efficient capturing of circulating tumor cells using a magnetic capture column and a size-selective filter.miRNA in situ hybridization in circulating tumor cells--MishCTC Circulating tumor cells in breast cancer: applications in personalized medicine.Circulating Tumor Cells After Neoadjuvant Chemotherapy in Stage I-III Triple-Negative Breast Cancer.Combined analysis of copy number alterations by single-nucleotide polymorphism array and MYC status in non-metastatic breast cancer patients: comparison according to the circulating tumor cell status.CD133 expression in circulating tumor cells from breast cancer patients: potential role in resistance to chemotherapy.Molecular characterization of circulating tumor cells from patients with metastatic breast cancer reflects evolutionary changes in gene expression under the pressure of systemic therapy.A comprehensive study of circulating tumour cells at the moment of prostate cancer diagnosis: biological and clinical implications of EGFR, AR and SNPs.Going with the flow: from circulating tumor cells to DNA.Comparison of circulating tumor cells (CTC) in peripheral blood and disseminated tumor cells in the bone marrow (DTC-BM) of breast cancer patients.Circulating tumor cells in breast cancer and its association with tumor clinicopathological characteristics: a meta-analysis.

P2860

Q26748850-356D034B-01E0-4E7C-95AC-B60845805632 Q26774808-C26DE724-7DD0-42F1-8131-9AD0881B0141 Q30590270-A5F7EE79-F2BD-484D-9C04-33F21B49134B Q33839150-0DDE645E-4FCD-4F85-A855-E458C950A431 Q34077349-289CBCA5-B8C4-443F-A435-0A8F79637A7D Q34365738-A7D758A6-0410-4A2B-94D4-D756B61A0BD6 Q34994963-A9B8DBD4-C76B-4188-A92B-439547EC94CE Q35093762-EDE2541E-F39A-4F84-80A3-445601072A1C Q35201525-E4F29C8B-5B78-44A6-AF71-0613EB9B626E Q35619770-3B14CFF1-A919-4990-9834-A8D4360410CC Q35836555-C4642C32-DED1-4D56-9C13-85D574BECBC6 Q35935317-1DC4AF38-8CC7-46F1-BE77-87C26E50AE16 Q36119176-D45E985A-FCB3-4F0D-AC61-85E694529830 Q36321612-E5A9DD7C-C18D-42FD-8D2B-5BE334456961 Q36547904-9EA216AE-0034-473C-93BA-F4086355F854 Q37274573-B236EF49-70BC-4623-97D7-66FADE75B6EA Q37352090-60DE561A-94A4-44D2-B8C7-A0DB1A8436A2 Q37427008-E0774D29-197B-48DE-B68E-7C902A2F0D83 Q37693504-F09EFF9F-002A-4B37-B47D-ED2350D62747 Q38070396-67B3D8EF-1D5A-4037-ABB6-1B5DA87ED111 Q38097525-BA35E252-EC1C-4AFF-BA77-14BB435F5423 Q38109808-19BC9077-4A24-4125-9570-48A06AF524C5 Q38124901-4848C5BB-5DCC-46B8-9B9E-400984CAF691 Q38152315-FBA89808-218D-4D50-BCC5-22979DBF9D77 Q38196920-4A31DD5A-36C7-43D8-B70F-E369C66269F3 Q38633382-819D1827-D513-4D2D-AD18-AB982AD4525A Q38676889-DEA3F862-9372-4B75-9165-8501DBA878CF Q38735156-C415EC75-512C-46A5-AA89-08BB0EE789E3 Q38821891-D0B05BE6-0A17-4958-B830-0F28FA1D71A2 Q38876246-C27DDAC6-E3A7-4573-B048-C54FF55A85FE Q38899010-948350E6-35FF-4698-AA94-10A76DD34FEE Q38985771-36C55238-252A-4AF3-AE40-65CBA53F592B Q39007492-55C8C93A-4868-49A5-8140-B9E41E667FC8 Q39117990-DF0C7D3B-4170-4DA2-9B10-13836B234E9B Q39153898-8873B98F-E2D8-4964-A6AA-4BB2B667F7B9 Q41233528-65082E76-CFB9-4776-9AC3-C52C69CD37B1 Q42378445-634E8EB3-40DC-40E0-8F93-CAA240674DC5 Q43826044-D8519E2D-FD67-4E0F-A877-ED360508EFD5 Q44396376-A31A0EE5-81FD-44C2-AA15-A2AB486A404F Q45141198-248D2338-F067-46E1-9B39-889E008AB223

P2860

Biomarkers characterization of circulating tumour cells in breast cancer patients

http://www.wikidata.org/entity/Q36245346

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Biomarkers characterization of circulating tumour cells in breast cancer patients

@ast

Biomarkers characterization of circulating tumour cells in breast cancer patients

@en

type

label

Biomarkers characterization of circulating tumour cells in breast cancer patients

@ast

Biomarkers characterization of circulating tumour cells in breast cancer patients

@en

prefLabel

Biomarkers characterization of circulating tumour cells in breast cancer patients

@ast

Biomarkers characterization of circulating tumour cells in breast cancer patients

@en

P1433

Q36245346-56FFFCA1-1798-48B3-A4A5-3EC881BEC717

P1476

Q36245346-DD20E178-7F2E-43BB-97DC-B97FB8CFB30B

P2093

Q36245346-01C50989-D5A9-4E4C-9527-B0E23B91E799

Q36245346-18A19A70-B81F-4EC1-90F3-A4390AD27DBC

Q36245346-2D6D3AC8-C8B2-4228-8338-BED3BB1D9BA7

Q36245346-309650DE-D51B-48C0-96F3-B4DEA6449070

Q36245346-6E05D82D-BCE8-465A-8488-F892A5A9A3B0

Q36245346-859D8137-54B0-4ABB-B3EA-4A44237F791D

Q36245346-916F2F3A-3E29-4684-A510-B81021DB9427

Q36245346-BB14267B-F470-4122-9ECC-621C509ABB27

Q36245346-BF389D54-99D1-4925-82F6-A761311C5BCB

Q36245346-C5A36ED7-0B7D-4F1C-A820-538DCE3044B7

P2860

Q36245346-0040A42C-9D9A-4605-BA67-6B54EE013FE8

Q36245346-03DF7E29-0328-4090-8F2E-C8B8E701410C

Q36245346-0BE270BE-C3DF-484B-967A-11F2D13C92BD

Q36245346-113ABFB7-76DC-46CA-AA4E-9D7207613A9F

Q36245346-11BADDF6-F17B-4A6A-9B02-40DC2296E0D4

Q36245346-140C61C3-9910-4811-9C20-AAA04E266E93

Q36245346-16632942-E8F4-4BB6-9F75-F563F622DB74

Q36245346-226E60CD-68C9-4878-A39E-488F5871284E

Q36245346-22C6B750-57A0-42B3-B85D-BE17735932E2

Q36245346-385695BE-FD0B-4B49-B394-786770DC3E3A

P2888

Q36245346-3D5753E9-A15B-41EE-BD30-86E4D41732F3

P304

Q36245346-8EBBF5F4-04FE-49F5-AF35-BDDC34C4AA97

P31

Q36245346-2BC90956-B627-47E7-B3C1-15B529115639

P356

Q36245346-FEE1B753-8607-4575-B99B-5E75953A2FB5

P433

Q36245346-438E3894-861B-43C3-8636-E02EA864E5DC

P478

Q36245346-A8841DD6-0511-40E5-BF61-F1CA82B49F47

P50

Q36245346-082F213D-D6AC-4C86-9BFB-9638A829C626

P577

Q36245346-01C41842-266E-42A5-976E-DF62565073AE

P5875

Q36245346-BC858713-4659-44DA-96E2-77ECC355DA7B

P6179

Q36245346-FC0081E1-B0E4-43A2-A6C2-E2F7D0FB494A

P698

Q36245346-3198E46E-F292-4952-BB63-E00EB17A8147

P921

Q36245346-70BD7D11-B1BD-48E8-8D17-13C2C4B53EB9

P932

Q36245346-CD7AD602-A7BE-4639-9B97-DED47116AD50

P356

P1433

Breast Cancer Research

P1476

Biomarkers characterization of circulating tumour cells in breast cancer patients

@en

P2093

Ana Fernandez

http://www.w3.org/2001/XMLSchema#string

Francesc Solé

http://www.w3.org/2001/XMLSchema#string

Joan Albanell

http://www.w3.org/2001/XMLSchema#string

Josep Maria Corominas

http://www.w3.org/2001/XMLSchema#string

José Luis García-Puche

http://www.w3.org/2001/XMLSchema#string

Lucas Gonzalez

http://www.w3.org/2001/XMLSchema#string

Marta Macià

http://www.w3.org/2001/XMLSchema#string

Marta Salido

http://www.w3.org/2001/XMLSchema#string

María José Serrano

http://www.w3.org/2001/XMLSchema#string

María Rodríguez

http://www.w3.org/2001/XMLSchema#string

P2860

AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor

HER-2 gene amplification can be acquired as breast cancer progresses

Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry.

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Cancer statistics, 2010

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Molecular portraits of human breast tumours

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis

Molecular biomarker analyses using circulating tumor cells

P2888

P304

R71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR3180

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

José Antonio Lorente

P577

2012-05-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224895378

http://www.w3.org/2001/XMLSchema#string

P6179

1012991924

http://www.w3.org/2001/XMLSchema#string

P698

22554015

http://www.w3.org/2001/XMLSchema#string

P921

P932

3446333

http://www.w3.org/2001/XMLSchema#string